12.06.2012 • NewsSadaraSaudi AramcoDow Chemical

Aramco, Dow Petchem JV Picks Banks for Project Sukuk

Sadara, the $20 billion petrochemical joint venture between oil giant Saudi Aramco and Dow Chemical, picked four banks to manage the Islamic bond, or sukuk, portion of its multi-billion dollar fundraising, three sources said on Tuesday.

Deutsche Bank, Riyad Bank, Alinma Bank and Bank Al Bilad have been mandated for the deal, likely to be denominated in riyals, which will be only the second project finance sukuk ever to be raised in Saudi Arabia.

Earmarked to raise around $1.4 billion, the sukuk is not expected to be marketed until next year, two sources said.

It is part of a $12.5 billion debt package currently being raised to fund the construction of the project, which will produce more than 3 million tons of petrochemicals each year when completed in 2016.

"The sukuk will take at least nine months to pull together," said one banker with knowledge of the matter, speaking on condition of anonymity as the information isn't public.

"They have appointed the banks as they need to start now. Getting it registered and approved by the Capital Markets Authority (the Saudi regulator) takes a long time."

Saudi Aramco wasn't immediately available for comment.

The only project sukuk in Saudi thus far was the 3.75 billion riyals ($1 billion) issue in October from Saudi Aramco Total Refining and Petrochemical (SATORP), a joint venture between Aramco and France's Total.

However, while initially envisaged to be sold at the same time as the bank finance was arranged, the SATORP sukuk was completed more than 15 months after the loans were signed.

This was due to concerns among Islamic scholars about the sharia-compliance of using an unbuilt asset, not generating any revenue, as security - Islamic finance is based on the concept of risk/revenue sharing, with interest payments forbidden.

Such issues won't affect Sadara's sukuk as the SATORP offering provides a template to work from.

"The structure from SATORP is in place, although there will be some changes as the (SATORP) structure is quite simple," the same source said.

As well as the sukuk, the sponsors have also invited banks to bid for a $4 billion commercial loan, which is expected to include 16-year bank financing and a 17-year tranche from export credit agencies, loan bankers said.

The loan, which includes U.S. dollar and Saudi riyal tranches, is priced at what is widely considered a very competitive 45 basis points (bps), the loans bankers added.

"The sponsors are pushing very hard for big tickets, as well as pushing hard on the pricing," one European loan banker said. "There is a lot pressure on relationship banks to look at this."

Additional loans from export credit agencies will be used to raise the $12.5 billion target.

Much of the focus is expected to be placed on Saudi banks to provide loan funding, as lending by international banks has been constrained by Europe's sovereign debt crisis and Basel III, which makes long-term lending more difficult because of capital requirements on banks.

Saudi banks have ample liquidity and keen to lend to quality borrowers, although much of their liquidity is in local currency and not dollars.

Meetings between Aramco, Dow and banks are scheduled to take place next week, one of the sources said, to discuss the funding options.

This follows the initial information memorandum being sent to banks at the end of last month, according to Project Finance International (PFI), a unit of Thomson Reuters.

Royal Bank of Scotland and Riyad Bank are the advisors on the project.

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

most read

Photo
27.03.2025 • News

J&J to Invest $55 Billion in US Operations

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25% increase compared to the previous four years, the company said.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.